# Daily Temporal Associations Between Psychoactive Substance Use and MS Symptoms > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/psychoactive-substance-use-multiple-sclerosis-daily-associations/ > **Published:** 2026-04-10T06:07:54-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:06-04:00 > **Clinical Summary:** Explore psychoactive substance use multiple sclerosis and its daily associations with fatigue, pain, stress, and depressive symptoms in this ecological study. --- CED Clinical Relevance  #64Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic Multiple SclerosisPainCannabisOpioidsEma Journal Archives of physical medicine and rehabilitation Study Type [Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) Population Human participants Why This Matters Multiple sclerosis patients frequently use psychoactive substances to manage symptoms, but the temporal relationships between symptom fluctuations and substance use patterns remain poorly understood. This ecological momentary assessment study provides real-world data on how MS symptoms directly influence daily substance use decisions. Clinical Summary This longitudinal study used smartphone-based ecological momentary assessment to track 258 ambulatory adults with MS four times daily over 14 days at baseline, 1-year, and 2-year follow-ups. Researchers examined bidirectional temporal associations between momentary symptoms (fatigue, pain, stress, depression) and use of alcohol, caffeine, nicotine, cannabis, and opioids using mixed-effects regression models. Key findings showed that momentary stress increases predicted reduced alcohol use, while higher average pain was associated with decreased alcohol consumption and increased opioid use. The study’s strength lies in its real-time data collection minimizing recall bias, though the brief 14-day assessment periods may not capture longer-term patterns. Dr. Caplan’s Take “This study confirms what I observe clinically – MS patients aren’t simply self-medicating in predictable ways, and the relationship between symptoms and substance use is more nuanced than we often assume. The finding that stress actually decreased alcohol use challenges common assumptions about self-medication patterns.” Clinical Perspective 🧠 Clinicians should recognize that MS patients’ substance use patterns are complex and symptom-dependent, requiring individualized assessment rather than broad assumptions about self-medication. These findings suggest we need more sophisticated approaches to substance use counseling that account for the dynamic, bidirectional relationships between specific symptoms and different psychoactive substances. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Daily%20Temporal%20Associations%20Between%20Use%20of%20Psychoactive%20Substances%20and%20Fatigue%2C%20...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41633444/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41633444/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Daily%20Temporal%20Associations%20Between%20Use%20of%20Psychoactive%20Substances%20and%20Fatigue%2C%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41633444/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41633444/](https://pubmed.ncbi.nlm.nih.gov/41633444/) Table of Contents - [FAQ](#FAQ)[How does cannabis use relate to symptom management in MS patients?](#How_does_cannabis_use_relate_to_symptom_management_in_MS_patients) - [Does alcohol consumption help or worsen MS symptoms?](#Does_alcohol_consumption_help_or_worsen_MS_symptoms) - [What psychoactive substances do MS patients commonly use for symptom management?](#What_psychoactive_substances_do_MS_patients_commonly_use_for_symptom_management) - [How reliable is real-time symptom tracking compared to traditional clinical assessments?](#How_reliable_is_real-time_symptom_tracking_compared_to_traditional_clinical_assessments) - [Should clinicians be concerned about substance use patterns in MS patients?](#Should_clinicians_be_concerned_about_substance_use_patterns_in_MS_patients) - [Related](#Related) ## FAQ #### How does cannabis use relate to symptom management in MS patients? This study found that higher average pain levels were associated with increased [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in people with MS. The real-time ecological momentary assessment data suggests patients may be self-medicating with [cannabis for pain management](https://cedclinic.com/medical-cannabis-patient-benefits/), though the study design cannot establish causation. #### Does alcohol consumption help or worsen MS symptoms? The research indicates that momentary increases in stress actually predicted lower odds of alcohol use, and higher average pain was linked to reduced alcohol consumption. This suggests MS patients may be appropriately avoiding alcohol during symptomatic periods rather than using it for symptom relief. #### What psychoactive substances do MS patients commonly use for symptom management? The study tracked five psychoactive substances: alcohol, caffeine, nicotine, cannabis, and opioids. Cannabis and opioids showed the strongest associations with pain levels, suggesting these may be the primary substances used for symptom management in this population. #### How reliable is real-time symptom tracking compared to traditional clinical assessments? Ecological momentary assessment (EMA) provides more accurate data by capturing symptoms and substance use as they occur, rather than relying on recall during clinical visits. This study used smartphone-based EMA four times daily for 14 days across multiple time points, providing robust real-world evidence of symptom-substance use patterns. #### Should clinicians be concerned about substance use patterns in MS patients? The study reveals that MS patients appear to use substances strategically in response to symptoms rather than recreationally. Clinicians should engage in open discussions about substance use patterns, particularly cannabis and opioids for [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/), to ensure safe and effective symptom control strategies. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Daily Temporal Associations Between Use of Psychoactive Substances and Fatigue, Pain, Stress, and Depressive Symptoms in People With Multiple Sclerosis.](https://cedclinic.com/ms-patients-cannabis-pain-ecological-momentary-assessment-study/) A detailed ecological momentary assessment study exploring how MS symptoms influence psychoactive substance use patterns in real time. [Read More](https://cedclinic.com/ms-patients-cannabis-pain-ecological-momentary-assessment-study/) [Medical Cannabis Linked to Meaningful Pain-Related Improvements in Large Minnesota Study](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) Explore findings on how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) contributes to pain relief, relevant for MS patients managing chronic symptoms. [Explore Study](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) [Why Older Adults Increasingly Seek Cannabis for Pain, Mental Health, & Sleep](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) Insights into the growing use of cannabis among older adults for symptom management, including pain and mental health challenges. [Learn More](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).